[go: up one dir, main page]

ES515472A0 - Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis. - Google Patents

Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.

Info

Publication number
ES515472A0
ES515472A0 ES515472A ES515472A ES515472A0 ES 515472 A0 ES515472 A0 ES 515472A0 ES 515472 A ES515472 A ES 515472A ES 515472 A ES515472 A ES 515472A ES 515472 A0 ES515472 A0 ES 515472A0
Authority
ES
Spain
Prior art keywords
procedure
hepatitis infection
susceptible hosts
protect susceptible
hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES515472A
Other languages
English (en)
Other versions
ES8404188A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of ES515472A0 publication Critical patent/ES515472A0/es
Publication of ES8404188A1 publication Critical patent/ES8404188A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES515472A 1981-09-04 1982-09-03 Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis. Expired ES8404188A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29945281A 1981-09-04 1981-09-04

Publications (2)

Publication Number Publication Date
ES515472A0 true ES515472A0 (es) 1984-04-16
ES8404188A1 ES8404188A1 (es) 1984-04-16

Family

ID=23154848

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515472A Expired ES8404188A1 (es) 1981-09-04 1982-09-03 Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.

Country Status (6)

Country Link
EP (1) EP0074248B1 (es)
JP (1) JPS5883631A (es)
AT (1) ATE18007T1 (es)
AU (1) AU554859B2 (es)
DE (1) DE3269188D1 (es)
ES (1) ES8404188A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248565B (it) * 1991-06-27 1995-01-19 Erba Carlo Spa Anticorpi policlonali anti-irudina e loro utilizzo per la identificazione, l`immunopurificazione e la determinazione quantitativa dell`uridina.
US6719975B1 (en) 1991-06-27 2004-04-13 Farmitalia Carlo Erba S.R.L. Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
ES2330904B1 (es) 2005-09-21 2010-09-23 Fundacio Centre De Recerca En Sanitat Animal Polinucleotidos de haemophilus parasuis y su uso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046871A (en) * 1975-04-08 1977-09-06 Ortho Diagnostics Inc. Compositions and serological methods including bovine serum albumin polymers

Also Published As

Publication number Publication date
ATE18007T1 (de) 1986-03-15
AU8778582A (en) 1983-03-10
ES8404188A1 (es) 1984-04-16
EP0074248A3 (en) 1983-09-28
EP0074248A2 (en) 1983-03-16
JPS5883631A (ja) 1983-05-19
DE3269188D1 (en) 1986-03-27
AU554859B2 (en) 1986-09-04
EP0074248B1 (en) 1986-02-19

Similar Documents

Publication Publication Date Title
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
IT8747856A0 (it) Adiuvante immunologico per vaccini polisaccaridici
ATE162402T1 (de) Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff
CA2121241A1 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
UA40596C2 (uk) Композиція вакцини та спосіб її одержання
ATE79548T1 (de) Herpes simplex virus subunitimpfstoff.
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
NL990018I1 (nl) Vaccin tegen Pasteurella.
ES515472A0 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
DK196687D0 (da) Kombineret vaccine, samt fremgangsmaade til fremstilling deraf
FI932759A0 (fi) Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner
DE69103130D1 (de) Zellfreies Marekskrankheitvirus-Vakzin.
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
ES2091159A1 (es) Antigeno recombinante, rsm14, procedente de schistosoma mansoni, su obtencion y utilizacion.
NO177555C (no) Fremgangsmåte for fremstilling av en vaksine mot FIP virus
FI871131A0 (fi) Menetelmä rokotteen valmistamiseksi
NL300073I1 (nl) Vaccin.
AR244552A1 (es) Procedimiento para la preparacion de una composicion de aplicacion en veterinaria, que incluye una vacuna y un inmunoestimulante como amplificador de la respuesta inmunologica de dicha vacuna.
GB8608991D0 (en) Virus vaccine
GR3003377T3 (en) Virus vaccine
NO891355D0 (no) Vaksinasjon mot rabis-beslektede virus.